Search research articles
Contact Us
Filters
Showing results (141-150 of 238) with videos related to
Page
of 24
Sort By:
Liver Cancer
|
October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Dominik Bettinger, David J Pinato, Michael Schultheiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Michele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
JAMA Oncology
|
December 26, 2024
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
October 18, 2023
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer
Abdul Rafeh Naqash, Justin D McCallen, Emma Mi, et al.
Journal for Immunotherapy of Cancer
|
October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
David J Pinato, Ahmed Kaseb, Yinghong Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors
Maria Vieito, Elisa Fontana, Catherine H Han, et al.
JAMA Network Open
|
June 4, 2025
Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders
Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, et al.
Cambridge Prisms. Precision Medicine
|
February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunities
Charles Craddock, Philip Earwaker, Matthew Fittall, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 238) with videos related to
Sort By:
Page
of 24
Liver Cancer
|
October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Dominik Bettinger, David J Pinato, Michael Schultheiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Michele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
JAMA Oncology
|
December 26, 2024
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer
Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
October 18, 2023
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer
Abdul Rafeh Naqash, Justin D McCallen, Emma Mi, et al.
Journal for Immunotherapy of Cancer
|
October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
David J Pinato, Ahmed Kaseb, Yinghong Wang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 22, 2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Edouard Auclin, Jose Benitez-Montanez, Marco Tagliamento, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors
Maria Vieito, Elisa Fontana, Catherine H Han, et al.
JAMA Network Open
|
June 4, 2025
Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders
Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, et al.
Cambridge Prisms. Precision Medicine
|
February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunities
Charles Craddock, Philip Earwaker, Matthew Fittall, et al.
Page
of 24